SCHEMBL16259646

SCHEMBL16259646

CC(C)c1ccc(C(=O)N(C)C)c(C(C)(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.38
HIF1A Q16665 1/20 0.38
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CXCR1 P25024 3/20 0.34
CXCR2 P25025 3/20 0.34
RNASEH1 O60930 1/20 0.34
CYP26A1 O43174 1/20 0.34
KMT2A Q03164 2/20 0.33
KEAP1 Q14145 1/20 0.33
TYR P14679 1/20 0.33
ATM Q13315 1/20 0.33
MEN1 O00255 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TRPA1 O75762 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16259650 0.88 CYP2D6 (0.39) CYP2D6HSP90AA1HSP90AB1CYP1A2CYP2C9
SCHEMBL16259642 0.84 HSP90AA1 (0.40) CYP2D6HSP90AA1HSP90AB1CYP1A2CYP2C9
SCHEMBL10699529 0.83 CYP2C9 (0.46) CYP2D6CYP2C9HIF1AALDH1A1KMT2A
SCHEMBL21372545 0.79 CYP2D6 (0.39) CYP2D6HSP90AA1HSP90AB1CYP1A2CYP2C9
SCHEMBL16261247 0.78 SMN1; SMN2 (0.39) HSP90AA1HSP90AB1NPC1ALDH1A1KMT2A
SCHEMBL10169806 0.77 HSP90AA1 (0.43) HSP90AA1HSP90AB1NPC1RAB9AALDH1A1
SCHEMBL10169804 0.77 ALDH1A1 (0.47) HSP90AA1HSP90AB1NPC1RAB9AALDH1A1
SCHEMBL16259637 0.76 POLB (0.40) CYP2D6CYP1A2CYP2C9HIF1AALDH1A1
SCHEMBL12548601 0.75 TRPA1 (0.48) HSP90AA1HSP90AB1NPC1RAB9AALDH1A1
SCHEMBL19590684 0.74 HSPA5 (0.39) HSP90AA1HSP90AB1CYP2C9ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9815851-B2 Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases PHENEX PHARMACEUTICALS AG (DE) 2017-11-14 US disclosed
US-9815851-B2 Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases PHENEX PHARMACEUTICALS AG (DE) 2017-11-14 US disclosed
US-20140349987-A1 PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORy, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES PHENEX PHARMACEUTICALS AG (DE) 2014-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140349987-A1 PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORy, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES RORA, RORB, RORC CYP2D6 1674/4885HSP90AA1 3140/4885HSP90AB1 3052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.